JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
781
6204–23. (f) Ching HYV, Wang X, He M, et al. Rhenium com- 15. Chambers JM, Hill PA, Aaron JA, et al. Cryptophane Xenon-
plexes based on 2-pyridyl-1,2,3-triazole ligands: a new class
129 nuclear magnetic resonance biosensors targeting
of CO reduction catalysts. Inorg Chem 2017;56:2966–76. (g)
human carbonic anhydrase. J Am Chem Soc 2009;131:563–9.
2
Kim TY, Elliott ABS, Shaffer KJ, et al. Rhenium(I) complexes 16. Sheldrick GM. Crystal structure refinement with SHELXL.
Acta Crystallogr C Struct Chem 2015;71:3–8.
7. Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09, revi-
sion A.1. Wallingford CT: Gaussian, Inc.; 2009.
8. Dennington IIR, Keith T, Milliam J, GaussView version 4.1.2.
Shawnee Mission, KS: Semichem Inc.; 2007.
9. (a) Lee C, Yang W, Parr RG. Development of the Colle-
Salvetti correlation-energy formula into a functional of the
electron density. Phys Rev B 1988;37:785–9. (b) Becke AD.
Density-functional thermochemistry. III. The role of exact
exchange. J Chem Phys 1993;98:5648–52.
0. Hay PJ, Wadt WR. Ab initio effective core potentials for
molecular calculations. Potentials for K to Au including the
outermost core orbitals. J Chem Phys 1985;82:299–310.
1. Glendening ED, Badenhoop JK, Reed AE, et al. NBO 6.0.
Theoretical chemistry institute. Madison: University of
Wisconsin; 2013.
of readily functionalized bidentate pyridyl-1,2,3-triazole
click” ligands: a systematic synthetic, spectroscopic and
1
1
1
“
computational study. Polyhedron 2013;52:1391–8. (h) Lo
WKC, Huff GS, Cubanski JR, et al. Comparison of inverse and
regular 2-pyridyl-1,2,3-triazole “click” complexes: structures,
stability, electrochemical, and photophysical properties.
Inorg Chem 2015;54:1572–87.
1
1
1. Obata M, Kitamura A, Mori A, et al. Syntheses, structural
characterization and photophysical properties of 4-(2-pyr-
idyl)-1,2,3-triazole rhenium(I) complexes. Dalton Trans 2008;
2
2
2
3292–300.
2. (a) Seridi A, Wolff M, Boulay A, et al. Rhenium(I) and
technetium(I) complexes of a novel pyridyltriazole-based lig-
and containing an arylpiperazine pharmacophore: synthesis,
crystal structures, computational studies and radiochemistry.
Inorg Chem Commun 2011;14:238–42. (b) Kilpin KJ, Gavey
EL, McAdam CJ, et al. Palladium(II) Complexes of readily
functionalized bidentate 2-pyridyl-1,2,3-triazole “click”
ligands: a synthetic, structural, spectroscopic, and computa-
tional study. Inorg Chem 2011;50:6334–46.
2. (a) Casida ME, Jamorski C, Casida KC, et al. Molecular excita-
tion energies to high-lying bound states from time-depend-
ent density-functional response theory: characterization and
correction of the time-dependent local density approximation
ionization threshold.
J Chem Phys 1998;108:4439. (b)
€
1
3. (a) G u€ zel-Akdemir O, Akdemir A, Karal N, et al. Discovery of
Stratmann RE, Scuseria GE, Frisch MJ. An efficient implemen-
tation of time-dependent density-functional theory for the
calculation of excitation energies of large molecules. J Chem
Phys 1998;109:8218. (c) Bauernschmitt R, Ahlrichs R.
Treatment of electronic excitations within the adiabatic
approximation of time dependent density functional theory.
Chem Phys Lett 1996;256:454–64.
novel isatin-based sulfonamides with potent and selective
inhibition of the tumor-associated carbonic anhydrase iso-
forms IX and XII. Org Biomol Chem 2015;13:6493–9. (b)
Carta F, Ferraroni M, Scozzafava A, et al. Fluorescent sulfona-
mide carbonic anhydrase inhibitors incorporating 1,2,3-tri-
azole moieties: kinetic and X-ray crystallographic studies.
Bioorg Med Chem 2016;24:104–12. (c) Pala N, Micheletto L, 23. (a) Canc ꢁe s E, Mennucci B, Tomasi J. A new integral equation
Sechi M, et al. Carbonic anhydrase inhibition with benzene-
sulfonamides and tetrafluorobenzenesulfonamides obtained
via click chemistry. ACS Med Chem Lett 2014;5:927–30. (d)
Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding
modes of inhibitors to carbonic anhydrases: how to design
specific drugs targeting 15 different isoforms? Chem Rev
formalism for the polarizable continuum model: theoretical
background and applications to isotropic and anisotropic
dielectrics. J Chem Phys 1997;107:3032. (b) Cossi M, Barone
V, Mennucci B, et al. Ab initio study of ionic solutions by a
polarizable continuum dielectric model. Chem Phys Lett
1
998;286:253–60. (c) Mennucci B, Tomasi J. Continuum solv-
ation models: a new approach to the problem of solute’s
charge distribution and cavity boundaries. J Chem Phys
2012;112:4421–68. (e) Winum JY, Supuran CT. Recent advan-
ces in the discovery of zinc-binding motifs for the develop-
ment of carbonic anhydrase inhibitors. J Enzyme Inhib Med
Chem 2015;30:321–4.
1
997;106:5151. (d) Cossi M, Scalmani G, Rega N, et al. New
developments in the polarizable continuum model for quan-
tum mechanical and classical calculations on molecules in
solution. J Chem Phys 2002;117:43.
1
4. (a) Akurathi V, Dubois L, Lieuwes NG, et al. Synthesis and
99m
biological evaluation of a
Tc-labelled sulfonamide conju-
2
4. Khalifah RG. The carbon dioxide hydration activity of car-
bonic anhydrase. I. Stop-flow kinetic studies on the native
human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
5. Sharma A, Tiwari M, Supuran CT. Novel coumarins and ben-
zocoumarins acting as isoform-selective inhibitors against
the tumor-associated carbonic anhydrase IX. J Enzyme Inhib
Med Chem 2014;29:292–6.
6. Durdagi S, Scozzafava G, Vullo D, et al. Inhibition of mam-
malian carbonic anhydrases I-XIV with grayanotoxin III: solu-
tion and in silico studies. J Enzyme Inhib Med Chem 2014;
gate for in vivo visualization of carbonic anhydrase IX
expression in tumor hypoxia. Nucl Med Biol 2010;37:557–64.
(
b) Lu G, Hillier SM, Maresca KP, et al. Synthesis and SAR of
2
9
9m
novel Re/ Tc-labeled benzenesulfonamide carbonic anhy-
drase IX inhibitors for molecular imaging of tumor hypoxia.
J Med Chem 2013;56:510–20. (c) Can D, Spingler B, Schmutz
99m
P, et al. (Cp-R)M(CO)
3
(M ¼ Re or
Tc) Arylsulfonamide,
2
2
arylsulfamide, and arylsulfamate conjugates for selective tar-
geting of human carbonic anhydrase IX. Angew Chem Int
Ed 2012;51:3354–7. (d) Nakai M, Pan J, Lin KS, et al.
2
9:469–75.
9
9m
Evaluation of
Tc-sulfonamide and sulfocoumarin deriva-
7. Alterio V, Hilvo M, Di Fiore A, et al. Crystal structure of the
catalytic domain of the tumor-associated human carbonic
anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233–8.
tives for imaging carbonic anhydrase IX expression. Inorg
Biochem 2018;185:63–70. (e) Huentupil Y, Pe n~ a L, Novoa N,
et al. New sulfonamides containing organometallicacylhydra- 28. La Regina G, Coluccia A, Famiglini V, et al. Discovery of 1,1’-
zones: synthesis, characterisation and biological evaluation
as inhibitors of human carbonic anhydrases. J Enzyme Inhib
Med Chem 2019;34:451–8.
biphenyl-4-sulfonamides as a new class of potent and
selective carbonic anhydrase XIV inhibitors. J Med Chem
2015;58:8564–72.